GSK plc (GSK)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 6 |
| Ownership rank: | 115 |
| % of all portfolios: | 0.094% |
| Hold Price * : | $55.19 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Hillman Capital Management |
3.73 |
Reduce 14.78% |
97,432 |
5,377,000 |
| ≡ |
Dodge & Cox Funds |
1.78 |
Reduce 14.38% |
58,662,974 |
3,237,610,000 |
| ≡ |
Kahn Brothers Group |
1.58 |
Reduce 9.91% |
160,982 |
8,885,000 |
| ≡ |
Tweedy Browne |
0.36 |
Reduce 0.56% |
81,785 |
4,514,000 |
| ≡ |
Sarah Ketterer - Causeway Capital Management |
0.01 |
Reduce 67.22% |
11,110 |
613,000 |
| ≡ |
Richard Pzena - Pzena Investment Management |
0.00 |
Add 40.01% |
18,823 |
1,039,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock